Skip to main content
Top
Published in: Tumor Biology 2/2012

01-04-2012 | Research Article

Distribution of mast cells in benign odontogenic tumors

Authors: Francisco de Assis Caldas Pereira, Clarissa Araújo Silva Gurgel, Eduardo Antônio Gonçalves Ramos, Manuela Torres Andion Vidal, Antônio Luiz Barbosa Pinheiro, Vladimir Jurisic, Caroline Brandi Schlaepfer Sales, Patrícia Ramos Cury, Jean Nunes dos Santos

Published in: Tumor Biology | Issue 2/2012

Login to get access

Abstract

The aim of this study was to investigate the presence of mast cells in a series of odontogenic tumors. Forty-five cases of odontogenic tumors were investigated using immunohistochemistry for mast cell triptase, and differences between groups were statistically evaluated. Mast cells were present in 96% of odontogenic tumors. Mast cells present in solid ameloblastoma were observed in the tumor stroma surrounding more solid and follicular epithelial islands, with or without squamous metaplasia. The odontogenic mixoma showed few mast cells. In odontogenic tumors with a cystic structure, the mast cells were distributed throughout all areas of the lesions, mainly in keratocystic odontogenic tumor. In addition, the total density of mast cells between all odontogenic tumors showed no significant difference (p > 0.05). A greater mast cells distribution was found in keratocystic odontogenic tumor in relation to adenomatoid odontogenic tumor (p < 0.01), and when the unicystic ameloblastoma and keratocistic odontogenic tumor were compared to the odontogenic myxoma (p < 0.05). Syndrome keratocystic odontogenic tumor showed a higher mean of mast cells when compared with the other tumors of the sample. Mast cells values presented by syndrome keratocystic odontogenic tumor were significantly greater than those of the sporadic keratocystic odontogenic tumor that were not associated with the syndrome (p = 0.03). Mast cells are probably one of the major components of the stromal scaffold in odontogenic tumors. We found significant differences of mast cells between syndrome nonsyndrome keratocystic odontogenic tumors, although their distribution did not seem to have any influence on the biologic behavior of benign odontogenic tumors.
Literature
1.
go back to reference Santos JN, Pinto LP, de Figueredo CR, Souza LB. Odontogenic tumors: analysis of 127 cases. Pesqui Odontol Bras. 2001;15:308–13.PubMedCrossRef Santos JN, Pinto LP, de Figueredo CR, Souza LB. Odontogenic tumors: analysis of 127 cases. Pesqui Odontol Bras. 2001;15:308–13.PubMedCrossRef
2.
go back to reference Jing W, Xuan M, Lin Y, Wu L, Liu L, Zheng X, Tang W, et al. Odontogenic tumours: a retrospective study of 1642 cases in a Chinese population. Int J Oral Maxillofac Surg. 2007;36:20–5.PubMedCrossRef Jing W, Xuan M, Lin Y, Wu L, Liu L, Zheng X, Tang W, et al. Odontogenic tumours: a retrospective study of 1642 cases in a Chinese population. Int J Oral Maxillofac Surg. 2007;36:20–5.PubMedCrossRef
3.
go back to reference Luo HY, Li TJ. Odontogenic tumors: a study of 1309 cases in a Chinese population. Oral Oncology. 2009;45:706–11.PubMedCrossRef Luo HY, Li TJ. Odontogenic tumors: a study of 1309 cases in a Chinese population. Oral Oncology. 2009;45:706–11.PubMedCrossRef
4.
go back to reference Tawfik MA, Zyada MM. Odontogenic tumors in Dakahlia, Egypt: analysis of 82 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109:67–73.CrossRef Tawfik MA, Zyada MM. Odontogenic tumors in Dakahlia, Egypt: analysis of 82 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109:67–73.CrossRef
5.
go back to reference Ledesma-Montes C, Mosqueda-Taylor A, Carlos-Bregni R, de Leon ER, Palma-Guzmán JM, Páez-Valencia C, Meneses-Garcia A. Ameloblastomas: a regional Latin-American multicentric study. Oral Dis. 2000;13:303–7.CrossRef Ledesma-Montes C, Mosqueda-Taylor A, Carlos-Bregni R, de Leon ER, Palma-Guzmán JM, Páez-Valencia C, Meneses-Garcia A. Ameloblastomas: a regional Latin-American multicentric study. Oral Dis. 2000;13:303–7.CrossRef
6.
go back to reference Rodewald HR, Dessing M, Dvorak AM, Galli SJ. Identification of a committed precursor for the mast cell lineage. Science. 1996;271:818–22.PubMedCrossRef Rodewald HR, Dessing M, Dvorak AM, Galli SJ. Identification of a committed precursor for the mast cell lineage. Science. 1996;271:818–22.PubMedCrossRef
7.
go back to reference Chen CC, Grimbaldeston MA, Tsai M, Weissman IL, Galli SJ. Identification of mast cell progenitors in adult mice. Proc Natl Acad Sci USA. 2005;102:11408–13.PubMedCrossRef Chen CC, Grimbaldeston MA, Tsai M, Weissman IL, Galli SJ. Identification of mast cell progenitors in adult mice. Proc Natl Acad Sci USA. 2005;102:11408–13.PubMedCrossRef
8.
go back to reference Fukushima H, Ohsawa M, Ikura Y, Naruko T, Sugama Y, Suekane T, Kitabayashi C, et al. Mast cells in diffuse large B-cell lymphoma; their role in fibrosis. Histopathology. 2006;49:498–505.PubMedCrossRef Fukushima H, Ohsawa M, Ikura Y, Naruko T, Sugama Y, Suekane T, Kitabayashi C, et al. Mast cells in diffuse large B-cell lymphoma; their role in fibrosis. Histopathology. 2006;49:498–505.PubMedCrossRef
9.
go back to reference Caughey GH. Mast cell tryptases and chymases in inflammation and host defense. Immunol Rev. 2007;217:141–54.PubMedCrossRef Caughey GH. Mast cell tryptases and chymases in inflammation and host defense. Immunol Rev. 2007;217:141–54.PubMedCrossRef
10.
go back to reference Maltby S, Khazaie K, McNagny KM. Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation. Biochim Biophys Acta. 2009;1796:19–26.PubMed Maltby S, Khazaie K, McNagny KM. Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation. Biochim Biophys Acta. 2009;1796:19–26.PubMed
12.
go back to reference Mangia A, Malfettone A, Rossi R, Paradiso A, Raniere G, Simone G, Restal L. Tissue remodeling in breast cancer: human mast cell tryptase as an initiator of myofibroblasts differentiation. Histopathology. 2011;58:1096–106.PubMedCrossRef Mangia A, Malfettone A, Rossi R, Paradiso A, Raniere G, Simone G, Restal L. Tissue remodeling in breast cancer: human mast cell tryptase as an initiator of myofibroblasts differentiation. Histopathology. 2011;58:1096–106.PubMedCrossRef
13.
go back to reference Ch’ng S, Wallis RA, Yuan L, Davis PF, Tan ST. Mast cells and cutaneous malignancies. Mod Pathol. 2006;19:149–59.PubMedCrossRef Ch’ng S, Wallis RA, Yuan L, Davis PF, Tan ST. Mast cells and cutaneous malignancies. Mod Pathol. 2006;19:149–59.PubMedCrossRef
14.
go back to reference Conti P, Castellani ML, Kempuraj D, Salini V, Vecchiet J, Tete S, Mastrangelo F, Perrella F, et al. Role of mast cells in tumor growth. Ann Clin Lab Sci. 2007;37:315–22.PubMed Conti P, Castellani ML, Kempuraj D, Salini V, Vecchiet J, Tete S, Mastrangelo F, Perrella F, et al. Role of mast cells in tumor growth. Ann Clin Lab Sci. 2007;37:315–22.PubMed
15.
go back to reference Ribatti D, Crivellato E, Molica S. Mast cells and angiogenesis in haematological malignancies. Leuk Research. 2009;33:876–9.CrossRef Ribatti D, Crivellato E, Molica S. Mast cells and angiogenesis in haematological malignancies. Leuk Research. 2009;33:876–9.CrossRef
16.
17.
go back to reference Barnes L, Eveson JW, Reichart P, Sidransky D. World Health Organization of tumours, pathology & genetics, head and neck tumours. Lyon: IARC press; 2005. Barnes L, Eveson JW, Reichart P, Sidransky D. World Health Organization of tumours, pathology & genetics, head and neck tumours. Lyon: IARC press; 2005.
18.
go back to reference Alaeddini M, Salah S, Dehghan F, Eshghyar N, Etemad-Moghadam S. Comparison of angiogenesis in keratocystic odontogenic tumours, dentigerous cysts and ameloblastomas. Oral Dis. 2009;15:422–7.PubMedCrossRef Alaeddini M, Salah S, Dehghan F, Eshghyar N, Etemad-Moghadam S. Comparison of angiogenesis in keratocystic odontogenic tumours, dentigerous cysts and ameloblastomas. Oral Dis. 2009;15:422–7.PubMedCrossRef
19.
go back to reference Silva Gurgel CA, Gonçalves Ramos EA, Araújo Melo L, Brandi Schlaepfer C, de Souza RO, Campos Oliveira M, Santos JN. Immunolocalisation of laminin-1 in keratocystic odontogenic tumors. Acta Histochem. 2010;112:624–9.PubMedCrossRef Silva Gurgel CA, Gonçalves Ramos EA, Araújo Melo L, Brandi Schlaepfer C, de Souza RO, Campos Oliveira M, Santos JN. Immunolocalisation of laminin-1 in keratocystic odontogenic tumors. Acta Histochem. 2010;112:624–9.PubMedCrossRef
20.
go back to reference Valent P, Schernthaner GH, Sperr WR, Fritsch G, Agis H, Willheim M, Buring HJ, et al. Variable expression of activation-linked surface antigens on human mast cells in health and disease. Immunol Rev. 2001;179:74–81.PubMedCrossRef Valent P, Schernthaner GH, Sperr WR, Fritsch G, Agis H, Willheim M, Buring HJ, et al. Variable expression of activation-linked surface antigens on human mast cells in health and disease. Immunol Rev. 2001;179:74–81.PubMedCrossRef
21.
go back to reference Huttunen M, Harvima IT. Mast cell tryptase and chymase in chronic leg ulcers: chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors. Br J Dermatol. 2005;152:1149–60.PubMedCrossRef Huttunen M, Harvima IT. Mast cell tryptase and chymase in chronic leg ulcers: chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors. Br J Dermatol. 2005;152:1149–60.PubMedCrossRef
22.
go back to reference Wayner A, Carter G, Piotrowicz S, Kunick TJ. The function of multiple extracellular matrix receptors in mediating cell adhesion to extracellular matrix: preparation of monoclonal antibodies to the fibronectin receptor that specifically inhibit cell adhesion to fibronectin and react with platelet glycoproteins Ic-IIa. J Cell Biol. 1988;107:1881–91.PubMedCrossRef Wayner A, Carter G, Piotrowicz S, Kunick TJ. The function of multiple extracellular matrix receptors in mediating cell adhesion to extracellular matrix: preparation of monoclonal antibodies to the fibronectin receptor that specifically inhibit cell adhesion to fibronectin and react with platelet glycoproteins Ic-IIa. J Cell Biol. 1988;107:1881–91.PubMedCrossRef
23.
go back to reference Dastuch J, Costa J, Thompson H, Metcalf TD. Mast cell adhesion to fibronectin. Immunology. 1991;73:478–84. Dastuch J, Costa J, Thompson H, Metcalf TD. Mast cell adhesion to fibronectin. Immunology. 1991;73:478–84.
24.
go back to reference Dastych J, Metcalfe DD. Stem cell factor induces mast cell adhesion to fibronectin. J Immunol. 1994;152:213–9.PubMed Dastych J, Metcalfe DD. Stem cell factor induces mast cell adhesion to fibronectin. J Immunol. 1994;152:213–9.PubMed
25.
go back to reference Santos JN, De Souza VF, Azevêdo RA, Sarmento VA, Souza LB. Braz “Hybrid” lesion of desmoplastic and conventional ameloblastoma: immunohistochemical aspects. Braz J Otorhinolaryngol. 2006;72:709–13.PubMed Santos JN, De Souza VF, Azevêdo RA, Sarmento VA, Souza LB. Braz “Hybrid” lesion of desmoplastic and conventional ameloblastoma: immunohistochemical aspects. Braz J Otorhinolaryngol. 2006;72:709–13.PubMed
26.
go back to reference Poomsawat S, Punyasingh J, Vejchapipat P. Expression of basement membrane components in odontogenic tumors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104:666–75.PubMedCrossRef Poomsawat S, Punyasingh J, Vejchapipat P. Expression of basement membrane components in odontogenic tumors. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104:666–75.PubMedCrossRef
27.
go back to reference de Medeiros AM, Nonaka CF, Galvão HC, de Souza LB, Freitas RA. Expression of extracellular matrix proteins in ameloblastomas and adenomatoid odontogenic tumors. Eur Arch Otorhinolaryngol. 2010;267:303–10.PubMedCrossRef de Medeiros AM, Nonaka CF, Galvão HC, de Souza LB, Freitas RA. Expression of extracellular matrix proteins in ameloblastomas and adenomatoid odontogenic tumors. Eur Arch Otorhinolaryngol. 2010;267:303–10.PubMedCrossRef
28.
go back to reference Smith G, Smith AJ, Basu MK. Mast cells in human odontogenic cysts. J Oral Pathol Med. 1989;18:274–8.PubMedCrossRef Smith G, Smith AJ, Basu MK. Mast cells in human odontogenic cysts. J Oral Pathol Med. 1989;18:274–8.PubMedCrossRef
29.
go back to reference Teronen O, Hietanen J, Lindqvist C, Salo T, Sorsa T, Eklund KK, Sommerhoff CP, et al. Mast cell-derived tryptase in odontogenic cysts. J Oral Pathol Med. 1996;25:376–81.PubMedCrossRef Teronen O, Hietanen J, Lindqvist C, Salo T, Sorsa T, Eklund KK, Sommerhoff CP, et al. Mast cell-derived tryptase in odontogenic cysts. J Oral Pathol Med. 1996;25:376–81.PubMedCrossRef
30.
go back to reference Roberts IS, Brenchley PE. Mast cells: the forgotten cells of renal fibrosis. J Clin Pathol. 2000;53:858–62.PubMedCrossRef Roberts IS, Brenchley PE. Mast cells: the forgotten cells of renal fibrosis. J Clin Pathol. 2000;53:858–62.PubMedCrossRef
31.
go back to reference Li CY, Baek JY. Mastocytosis and fibrosis: role of cytokines. Int Arch Allergy Immunol. 2002;127:123–6.PubMedCrossRef Li CY, Baek JY. Mastocytosis and fibrosis: role of cytokines. Int Arch Allergy Immunol. 2002;127:123–6.PubMedCrossRef
32.
go back to reference Kumamoto H, Ooya K. Immunohistochemical detection of platelet-derived endothelial cell growth factor/thymidine phosphorylase and angiopoietins in ameloblastic tumors. J Oral Pathol Med. 2006;35:606–12.PubMedCrossRef Kumamoto H, Ooya K. Immunohistochemical detection of platelet-derived endothelial cell growth factor/thymidine phosphorylase and angiopoietins in ameloblastic tumors. J Oral Pathol Med. 2006;35:606–12.PubMedCrossRef
33.
go back to reference Mitrou GK, Tosios KI, Kyroudi A, Skalavounou A. Odontogenic keratocyst expresses vascular endothelial growth factor: an immunohistochemical study. J Oral Pathol Med. 2009;38:470–5.PubMedCrossRef Mitrou GK, Tosios KI, Kyroudi A, Skalavounou A. Odontogenic keratocyst expresses vascular endothelial growth factor: an immunohistochemical study. J Oral Pathol Med. 2009;38:470–5.PubMedCrossRef
34.
go back to reference Stack M, Johnson D. Human mast cell tryptase activates single-chain urinary-type plasminogen activator. J Biol Chem. 1994;269:9416–19.PubMed Stack M, Johnson D. Human mast cell tryptase activates single-chain urinary-type plasminogen activator. J Biol Chem. 1994;269:9416–19.PubMed
35.
go back to reference Reed J, McNutt N, Bogdany J, Albino AP. Expression of the mast cell growth factor interleukin-3 in melanocytic lesions correlates with an increased number of mast cells in the perilesional stroma: implications for melanoma progression. J Cutan Pathol. 1996;23:495–505.PubMedCrossRef Reed J, McNutt N, Bogdany J, Albino AP. Expression of the mast cell growth factor interleukin-3 in melanocytic lesions correlates with an increased number of mast cells in the perilesional stroma: implications for melanoma progression. J Cutan Pathol. 1996;23:495–505.PubMedCrossRef
36.
go back to reference Ribatti D, Vacca A, Ria R, Marzullo A, Nico B, Filotico R, Roncali L, et al. Neovascularization, expression of fibroblast growth factor-2, and mast cells with tryptase activity increase simultaneously with pathological progression in human malignant melanoma. Eur J Cancer. 2003;39:666–74.PubMedCrossRef Ribatti D, Vacca A, Ria R, Marzullo A, Nico B, Filotico R, Roncali L, et al. Neovascularization, expression of fibroblast growth factor-2, and mast cells with tryptase activity increase simultaneously with pathological progression in human malignant melanoma. Eur J Cancer. 2003;39:666–74.PubMedCrossRef
37.
go back to reference Fossiez F, Banchereau J, Murray R, Van Kooten C, Garrone P, Lebecque S. Interleukin-17. Int Rev Immunol. 1998;16:541–51.PubMedCrossRef Fossiez F, Banchereau J, Murray R, Van Kooten C, Garrone P, Lebecque S. Interleukin-17. Int Rev Immunol. 1998;16:541–51.PubMedCrossRef
38.
go back to reference Yang Z, Zhang B, Li D, Huang C, Shen GX, Huang B. Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model. PLoS ONE. 2010;5:e8922.PubMedCrossRef Yang Z, Zhang B, Li D, Huang C, Shen GX, Huang B. Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model. PLoS ONE. 2010;5:e8922.PubMedCrossRef
39.
go back to reference Ahmed A, Powers MP, Youker KA, Rice L, Ewton E, Dunphy CH, Chang CC. Mast cell burden and reticulin fibrosis in the myeloproliferative neoplasms: a computer-assisted image analysis study. Pathol Res Pract. 2009;205:634–8.PubMedCrossRef Ahmed A, Powers MP, Youker KA, Rice L, Ewton E, Dunphy CH, Chang CC. Mast cell burden and reticulin fibrosis in the myeloproliferative neoplasms: a computer-assisted image analysis study. Pathol Res Pract. 2009;205:634–8.PubMedCrossRef
40.
go back to reference Fujiwara H, Konno R, Netsu S, Sugamata M, Ohwada M, Suzuki M. Localization of mast cells in endometrial cysts. Am J Reprod Immunol. 2004;51:341–4.PubMedCrossRef Fujiwara H, Konno R, Netsu S, Sugamata M, Ohwada M, Suzuki M. Localization of mast cells in endometrial cysts. Am J Reprod Immunol. 2004;51:341–4.PubMedCrossRef
41.
go back to reference Drazić R, Sopta J, Minić AJ. Mast cells in periapical lesions: potential role in their pathogenesis. J Oral Pathol Med. 2010;39:257–62.PubMedCrossRef Drazić R, Sopta J, Minić AJ. Mast cells in periapical lesions: potential role in their pathogenesis. J Oral Pathol Med. 2010;39:257–62.PubMedCrossRef
42.
go back to reference Farahani SS, Navabazam A, Ashkevari FS. Comparison of mast cells count in oral reactive lesions. Pathol Res Pract. 2010;206:151–5.PubMedCrossRef Farahani SS, Navabazam A, Ashkevari FS. Comparison of mast cells count in oral reactive lesions. Pathol Res Pract. 2010;206:151–5.PubMedCrossRef
43.
go back to reference Duncan L, Richards L, Mihm Jr M. Increased mast cell density in invasive melanoma. J Cutan Pathol. 1998;25:11–5.PubMedCrossRef Duncan L, Richards L, Mihm Jr M. Increased mast cell density in invasive melanoma. J Cutan Pathol. 1998;25:11–5.PubMedCrossRef
44.
go back to reference Humphreys TR, Monteiro MR, Murphy GF. Mast cells and dendritic cells in basal cell carcinoma stroma. Dermatol Surg. 2000;26:200–3. discussion 203–4.PubMedCrossRef Humphreys TR, Monteiro MR, Murphy GF. Mast cells and dendritic cells in basal cell carcinoma stroma. Dermatol Surg. 2000;26:200–3. discussion 203–4.PubMedCrossRef
45.
go back to reference Ribatti D, Ennas MG, Vacca A, Ferreli F, Nico B, Orru S, Sirigu P. Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma. Eur J Clin Invest. 2003;33(5):420–5.PubMedCrossRef Ribatti D, Ennas MG, Vacca A, Ferreli F, Nico B, Orru S, Sirigu P. Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma. Eur J Clin Invest. 2003;33(5):420–5.PubMedCrossRef
46.
go back to reference Madras J, Lapointe H. Keratocystic odontogenic tumour: reclassification of the odontogenic keratocyst from cyst to tumour. Tex Dent J. 2008;125:446–54.PubMed Madras J, Lapointe H. Keratocystic odontogenic tumour: reclassification of the odontogenic keratocyst from cyst to tumour. Tex Dent J. 2008;125:446–54.PubMed
47.
go back to reference Carlson ER, Marx RE. The ameloblastoma: primary, curative surgical management. J Oral Maxillofac Surg. 2006;64:484–94.PubMedCrossRef Carlson ER, Marx RE. The ameloblastoma: primary, curative surgical management. J Oral Maxillofac Surg. 2006;64:484–94.PubMedCrossRef
48.
go back to reference Pogrel MA, Montes DM. Is there a role for enucleation in the management of ameloblastoma? Int J Oral Maxillofac Surg. 2009;38:807–12.PubMedCrossRef Pogrel MA, Montes DM. Is there a role for enucleation in the management of ameloblastoma? Int J Oral Maxillofac Surg. 2009;38:807–12.PubMedCrossRef
49.
go back to reference Jaeger M, Santos J, Domingues M, Ruano R, Araújo N, Caroli A, Jaeger R. A novel cell line that retains the morphological characteristics of the cells and matrix of odontogenic myxoma. J Oral Pathol Med. 2000;29:129–38.PubMedCrossRef Jaeger M, Santos J, Domingues M, Ruano R, Araújo N, Caroli A, Jaeger R. A novel cell line that retains the morphological characteristics of the cells and matrix of odontogenic myxoma. J Oral Pathol Med. 2000;29:129–38.PubMedCrossRef
50.
go back to reference Martínez-Mata G, Mosqueda-Taylor A, Carlos-Bregni R, de Almeida OP, Contreras-Vidaurre E, Vargas PA, Cano-Valdez AM, et al. Odontogenic myxoma: clinico-pathological, immunohistochemical and ultrastructural findings of a multicentric series. Oral Oncol. 2008;44:601–7.PubMedCrossRef Martínez-Mata G, Mosqueda-Taylor A, Carlos-Bregni R, de Almeida OP, Contreras-Vidaurre E, Vargas PA, Cano-Valdez AM, et al. Odontogenic myxoma: clinico-pathological, immunohistochemical and ultrastructural findings of a multicentric series. Oral Oncol. 2008;44:601–7.PubMedCrossRef
51.
go back to reference Rick GM. Adenomatoid odontogenic tumor. Oral Maxillofac Surg Clin N Am. 2004;16:333–54.CrossRef Rick GM. Adenomatoid odontogenic tumor. Oral Maxillofac Surg Clin N Am. 2004;16:333–54.CrossRef
52.
go back to reference Santos JN, Lima FO, Romério P, Souza VF. Adenomatoid odontogenic tumor: an unusual case exhibiting cribriform aspect. Quintessence Int. 2008;39:777–81.PubMed Santos JN, Lima FO, Romério P, Souza VF. Adenomatoid odontogenic tumor: an unusual case exhibiting cribriform aspect. Quintessence Int. 2008;39:777–81.PubMed
53.
go back to reference Garg D, Palaskar S, Shetty VP, Bhusham A. Adenomatoid odontogenic tumor—hamartoma or true neoplasm: a case report. J Oral Sci. 2009;51:155–9.PubMedCrossRef Garg D, Palaskar S, Shetty VP, Bhusham A. Adenomatoid odontogenic tumor—hamartoma or true neoplasm: a case report. J Oral Sci. 2009;51:155–9.PubMedCrossRef
54.
go back to reference Zaitoun H, Triantfyllou A. Smooth muscle hamartoma of the hard palate. J Oral Pathol Med. 2007;36:245–9.PubMedCrossRef Zaitoun H, Triantfyllou A. Smooth muscle hamartoma of the hard palate. J Oral Pathol Med. 2007;36:245–9.PubMedCrossRef
Metadata
Title
Distribution of mast cells in benign odontogenic tumors
Authors
Francisco de Assis Caldas Pereira
Clarissa Araújo Silva Gurgel
Eduardo Antônio Gonçalves Ramos
Manuela Torres Andion Vidal
Antônio Luiz Barbosa Pinheiro
Vladimir Jurisic
Caroline Brandi Schlaepfer Sales
Patrícia Ramos Cury
Jean Nunes dos Santos
Publication date
01-04-2012
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 2/2012
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-011-0274-2

Other articles of this Issue 2/2012

Tumor Biology 2/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine